NASDAQ:ASND

Ascendis Pharma Earning Date

USA |NASDAQ |USD |ADR

ASND Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 9, 2021 Sep 2021 $-2.65 $-2.94 $-2.72
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 9, 2021 Sep 2021 $2.72M $1.02M $2.76M

Ascendis Pharma's next earnings date is Tuesday, Nov 9, 2021 for the fiscal quarter ending Sep 2021.

ASND Earnings Date & History Chart

ASND Earnings & Revenue Forecast

ASND Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-2.75 $-3.65 $-1.79
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $-9.58 $-10.25 $-8.28
Dec 2022 11 $-9.51 $-11.80 $-5.21

ASND Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.77 $-2.34 $-2.74
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-9.52 $-8.18 $-9.61
Dec 2022 0 / 1 $-9.38 $-8.06 $-9.43

ASND Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $8.13M $2.21M $29.37M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $15.52M $4.53M $43.97M
Dec 2022 13 $103.17M $49.94M $201.28M

ASND Earnings Date & Revenue History

ASND Earnings History

|
Show More
Show More

ASND Revenue History

|
Show More
Show More

Ascendis Pharma Next Earnings Date & Report

ASND Next Earnings Date & Report Preview: Sep 2021 (FQ)

ASND's next earnings date is Tuesday, Nov 9, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Ascendis Pharma's next quarterly earnings is $-2.65, with a low EPS estimation of $-2.98, and a high estimation of $-2.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-2.68, the last 2 month trend is $-2.21, and the 3 month trend is $-2.59.

Based on 9 analysts, the average revenue estimation is $2.72M, with a low revenue estimation of $0.00, and a high estimation of $12.54M.

Ascendis Pharma Previous Earnings Dates & Reports

ASND Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Ascendis Pharma's previous earnings date was Aug 25, 2021 for its fiscal quarter ended Jun 30, 2021.

ASND's earnings per share (EPS) was $-2.94, missing the consensus analysts forecast of $-2.64 by -11.31%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 106.14%, and lower than the same period a year before (Jun 2020) by 26.37%.

Revenues were $1.02M, better than the forecast of $1.02M by 0.00%, up by 37.00% from the previous quarter , and down by -28.83% from the same period last year.

The company reported a net income of $-134.37M.

Free cash flow for the quarter was $-118.78M , compared to $-86.17M last quarter and $-61.51M a year before.

ASND ended the quarter with $101.01M in total debt, an increase of 4.69% compared to the previous quarter, and an increase of 184.68% compared to the same quarter a year before.

ASND Previous Earnings Date & Report Recap: Dec 2020 (FY)

Ascendis Pharma's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.

ASND's earnings per share (EPS) was $-9.64, missing the consensus analysts forecast of $-8.13 by 18.58% , and lower than the previous year's EPS (Dec 2019) by 83.90%.

Revenues were $6.95M, worse than the forecast of $10.43M by -33.34%, and down by -48.01% from previous year's revenue.

The company reported a net income of $-418.95M.

Ascendis Pharma reported a free cash flow of $-293.10M for its fiscal year, compared to $-181.09M a year ago.

The company ended the fiscal year with $91.97M in total debt, an increase of 151.17% compared to the previous year.